Amylyx Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-07 12:23:22 ET AMLX

Published on 05/07/2026 at 12:23 pm EDT

Amylyx Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported net loss was USD 41.28 million compared to USD 35.91 million a year ago. Basic loss per share from continuing operations was USD 0.37 compared to USD 0.42 a year ago.

Diluted loss per share from continuing operations was USD 0.37 compared to USD 0.42 a year ago.